Source: FinanzNachrichten

Vivasure: Vivasure Medical: Vivasure Announces Positive Results of PATCH IDE Pivotal Study Indicating Safety and Efficacy of PerQseal Large Hole Closure Device

Data from U.S. IDE PATCH Pivotal Study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 annual conference will support a pre-market approval submission to the FDA Results demo...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Andrew Glass's photo - CEO of Vivasure

CEO

Andrew Glass

CEO Approval Rating

90/100

Read more